Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
NF-CERTOLIZUMAB PEGOL SUBQ SOLN 200MG/1M (CPT 50474-0710-81) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 5, 2026 , from http://ppman.hank.ai/transparency/procedure/50474-0710-81/by-state?code_type=CPT
“NF-CERTOLIZUMAB PEGOL SUBQ SOLN 200MG/1M (CPT 50474-0710-81) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/50474-0710-81/by-state?code_type=CPT. Accessed
July 5, 2026 .
“NF-CERTOLIZUMAB PEGOL SUBQ SOLN 200MG/1M (CPT 50474-0710-81) by State,” HANK Price Transparency ,
accessed July 5, 2026 ,
http://ppman.hank.ai/transparency/procedure/50474-0710-81/by-state?code_type=CPT.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CPT · across United States
50474-0710-81 — Nf-certolizumab Pegol Subq Soln 200mg/1m
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$12,111
National median
$10,336 – $16,611
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 50474-0710-81 (CPT), with interquartile range
State Median p25 p75
LA $12,111 $10,336 $16,611